SE8001691L - Guanidintiazolforeningar, forfarande for framstellning av dem och lekemedel som innehaller dem - Google Patents

Guanidintiazolforeningar, forfarande for framstellning av dem och lekemedel som innehaller dem

Info

Publication number
SE8001691L
SE8001691L SE8001691A SE8001691A SE8001691L SE 8001691 L SE8001691 L SE 8001691L SE 8001691 A SE8001691 A SE 8001691A SE 8001691 A SE8001691 A SE 8001691A SE 8001691 L SE8001691 L SE 8001691L
Authority
SE
Sweden
Prior art keywords
group
hydrogen atom
lower alkyl
guanidintiazol
societies
Prior art date
Application number
SE8001691A
Other languages
English (en)
Other versions
SE447253B (sv
Inventor
Y Hirata
I Yanagisawa
Y Ishii
M Takeda
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2574579A external-priority patent/JPS55118476A/ja
Priority claimed from JP7950879A external-priority patent/JPS565469A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of SE8001691L publication Critical patent/SE8001691L/sv
Publication of SE447253B publication Critical patent/SE447253B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE8001691A 1979-03-06 1980-03-05 Nya guanidinotiazolforeningar SE447253B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2574579A JPS55118476A (en) 1979-03-06 1979-03-06 Novel amidine derivative and its preparation
JP7950879A JPS565469A (en) 1979-06-23 1979-06-23 Novel amidine derivative and its preparation
KR1019800000932A KR830002478B1 (ko) 1979-03-06 1980-03-06 구아니디노 티아졸 화합물의 제조방법

Publications (2)

Publication Number Publication Date
SE8001691L true SE8001691L (sv) 1980-09-07
SE447253B SE447253B (sv) 1986-11-03

Family

ID=27285138

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001691A SE447253B (sv) 1979-03-06 1980-03-05 Nya guanidinotiazolforeningar

Country Status (11)

Country Link
US (1) US4362736A (sv)
CA (1) CA1145345A (sv)
CH (1) CH644114A5 (sv)
DE (1) DE3008056A1 (sv)
ES (1) ES489222A0 (sv)
FR (1) FR2450827A1 (sv)
GB (1) GB2052478B (sv)
IT (1) IT1165509B (sv)
NL (1) NL8001361A (sv)
PH (1) PH16099A (sv)
SE (1) SE447253B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IN158869B (sv) * 1981-03-18 1987-02-07 Ici Plc
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
JPS5872571A (ja) * 1981-10-27 1983-04-30 Shionogi & Co Ltd ２−グアニジノ−４−〔２−（ホルムアミド）エチルチオメチル〕チアゾ−ルの製法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0103390A3 (en) * 1982-08-13 1986-02-26 Imperial Chemical Industries Plc Guanidine-containing esters as histamine h2 receptor blockers
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JPS6160673A (ja) * 1984-08-30 1986-03-28 Yamanouchi Pharmaceut Co Ltd グアニジノチアゾ−ル誘導体の製造法
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
EP0284536A1 (en) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile
CA2053216C (en) 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
WO2015002150A1 (ja) 2013-07-03 2015-01-08 株式会社新日本科学 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
WO2021183259A1 (en) * 2020-03-12 2021-09-16 Nanopharmaceutics, Inc. Famotidine and famotidine analogs for corona virus treatment
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
DE2817078C2 (de) * 1977-04-20 1995-06-14 Zeneca Ltd Guanidinderivate
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法

Also Published As

Publication number Publication date
GB2052478A (en) 1981-01-28
PH16099A (en) 1983-06-24
DE3008056A1 (de) 1980-09-18
ES8103070A1 (es) 1981-02-16
DE3008056C2 (sv) 1988-07-21
FR2450827B1 (sv) 1983-03-25
IT1165509B (it) 1987-04-22
US4362736A (en) 1982-12-07
FR2450827A1 (fr) 1980-10-03
CA1145345A (en) 1983-04-26
ES489222A0 (es) 1981-02-16
IT8067346A0 (it) 1980-03-05
GB2052478B (en) 1983-04-07
CH644114A5 (de) 1984-07-13
NL8001361A (nl) 1980-09-09
SE447253B (sv) 1986-11-03

Similar Documents

Publication Publication Date Title
SE8001691L (sv) Guanidintiazolforeningar, forfarande for framstellning av dem och lekemedel som innehaller dem
ES2053524T3 (es) Un procedimiento para preparar un compuesto quimico.
SE7910568L (sv) Guanidinotiazolforeningar och forfarande for framstellning derav
MX9203239A (es) Derivados de 1-(dihidroxifenil)-2-amino-etanol y composiciones farmaceuticas que los contienen.
SE8104456L (sv) Hydantoinderivat, sett for framstellning derav och lekemedel innehallande dem
IL92632A0 (en) Substituted 2-pyridones and pyrid-2-thiones,their preparation and pharmaceutical compositions containing them
ES8306759A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
GB1471743A (en) Isoxazole derivatives
DE3660286D1 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
SE8203272L (sv) Karboximidderivat, forfaranden for framstellning derav och lekemedel innehallande dem
SE7714660L (sv) Aminosockerderivat, sett for framstellning derav samt anvendning derav som lekemedel
SE7704783L (sv) Medel for separationsendamal och forfarande for dess framstellning
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
MX9304467A (es) Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen.
ES2052954T3 (es) Derivados de imino-2-polifluoroalcoxi-6-benzotiazol, sus procedimientos de preparacion y los medicamentos que les contienen.
NL7612427A (nl) Werkwijze voor de bereiding van nieuwe chinoline- derivaten.
IE841653L (en) Rooperol and its derivatives
AR004949A1 (es) Derivados de benzoil-4-pirazol, procedimiento para obtenerlos, composiciones herbicidas que los contienen y procedimientos para combatirplantas indeseables.
ES466815A1 (es) Procedimiento de preparacion de (2-tio)ureas disustituidas en las posiciones 1 y 3.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
ES8200347A1 (es) Procedimiento de preparacion de derivados de la piridina.
JPS52100470A (en) Synthesis of hydantoin derivatives
IE39284B1 (en) Butyramides and butyrates
ES471872A1 (es) Un procedimiento de preparacion de tetrahidro-s-triazin-tio-nas acaricidas
ES8103096A1 (es) Un procedimiento para la preparacion de una penicilina.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8001691-8

Effective date: 19911009

Format of ref document f/p: F